Search - tctmd.com

Displaying 1 - 20 of 176

Sort: Relevancy | Date

$Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis$

News Daily News

Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis

August 13, 2025

Roughly Half of Patients Don’t Have Symptoms Prior to a First MI

News Daily News

Roughly Half of Patients Don’t Have Symptoms Prior to a First MI

July 09, 2025

Greater Frailty Means More Complications, Higher Mortality After PCI

News Daily News

Greater Frailty Means More Complications, Higher Mortality After PCI

June 16, 2025

Role of Inflammation in Coronary Heart Disease: Why Does it Matter

Presentation TCT 2024

Role of Inflammation in Coronary Heart Disease: Why Does it Matter

Presenter: Deepak Bhatt

October 29, 2024

Inflammation- Current and Emerging Therapeutic Landscape

Presentation TCT 2024

Inflammation- Current and Emerging Therapeutic Landscape

Presenter: Deepak Bhatt

October 29, 2024

Benefits of 12-Month DAPT After CABG Persist to 5 Years: DACAB

News Daily News

Benefits of 12-Month DAPT After CABG Persist to 5 Years: DACAB

Yael L. Maxwell

June 14, 2024

MULTISTARS AMI: Immediate Complete PCI in STEMI as Safe as Staged Revascularization

News Conference News ESC 2023

MULTISTARS AMI: Immediate Complete PCI in STEMI as Safe as Staged Revascularization

Michael O'Riordan

August 28, 2023

LDL Control Remains Poor in CAD Patients: NHANES

News Daily News

LDL Control Remains Poor in CAD Patients: NHANES

Michael O'Riordan

July 05, 2023

P2Y12 Monotherapy Better Than Continued DAPT Even After Complex PCI

News Daily News

P2Y12 Monotherapy Better Than Continued DAPT Even After Complex PCI

Yael L. Maxwell

February 06, 2023

New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT

News Daily News

New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT

July 08, 2022

BIO|GUARD-MI: Post-MI Arrhythmia Monitoring Falls Short

News Conference News ACC 2022

BIO|GUARD-MI: Post-MI Arrhythmia Monitoring Falls Short

April 11, 2022

Bentracimab Swiftly Reverses Ticagrelor, Platelet-Function Study Affirms

News Conference News ACC 2022

Bentracimab Swiftly Reverses Ticagrelor, Platelet-Function Study Affirms

April 02, 2022

Bentracimab Rapidly, Safely Reverses Ticagrelor in Early REVERSE-IT Data

News Conference News AHA 2021

Bentracimab Rapidly, Safely Reverses Ticagrelor in Early REVERSE-IT Data

Yael L. Maxwell

November 15, 2021

Finding the Sweet Spot: Balancing Reducing Ischemic Risk and Reducing Bleeding Risk with Antiplatelet Therapy

Presentation TCT 2021

Finding the Sweet Spot: Balancing Reducing Ischemic Risk and Reducing Bleeding Risk with Antiplatelet Therapy

Presenter: Deepak Bhatt

November 05, 2021

Antiplatelet Therapy for Patients with Diabetes Undergoing PCI

Presentation TCT 2021

Antiplatelet Therapy for Patients with Diabetes Undergoing PCI

Presenter: Deepak Bhatt

November 05, 2021

New Chest Pain Guidelines Out at Last: Most Tests Have a Role

News Daily News

New Chest Pain Guidelines Out at Last: Most Tests Have a Role

Michael O'Riordan

October 28, 2021

Clopidogrel, Not Aspirin, for Post-DAPT Monotherapy After PCI: HOST-EXAM

News Conference News ACC 2021

Clopidogrel, Not Aspirin, for Post-DAPT Monotherapy After PCI: HOST-EXAM

May 16, 2021

Use of a Rapid, High-Sensitivity Troponin Protocol Doesn’t Boost 1-Year Outcomes

News Conference News ACC 2021

Use of a Rapid, High-Sensitivity Troponin Protocol Doesn’t Boost 1-Year Outcomes

May 16, 2021

Even With Stent Cards, Patients Often Hazy on PCI Details Years Later

News Conference News ACC 2021

Even With Stent Cards, Patients Often Hazy on PCI Details Years Later

Michael O'Riordan

May 11, 2021

ISCHEMIA: PCI/CABG Has Early Hospitalization ‘Tax’ but Equals Meds Later

News Conference News SCAI 2021

ISCHEMIA: PCI/CABG Has Early Hospitalization ‘Tax’ but Equals Meds Later

Michael O'Riordan

May 06, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.